Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients. - Chuang, W.‐L.; Jia, J.; Chan, H. L. Y.; Han, K.‐H.; Tanwandee, T.; Tan, D.; Chen, X.; Gane, E.; Piratvisuth, T.; Chen, L.; Xie, Q.; Sung, J. J.‐Y.; et al. (Alimentary Pharmacology & Therapeutics, 2018)